EMILY JONES: Open Payments
NPI 1457824781 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 46 payments from 15 companies in 2025. Trend: 2023 $1,856 · 2024 $1,228 · 2025 $1,304
Food & beverage: $1,243Education: $61
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $290 |
| Novartis Pharmaceuticals Corporation | 11 | $246 |
| Janssen Biotech, Inc. | 4 | $164 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $101 |
| Lilly USA, LLC | 1 | $92 |
| GENZYME CORPORATION | 2 | $72 |
| ABBVIE INC. | 4 | $62 |
| Galderma Laboratories, L.P. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Amgen Inc. | 2 | $49 |
Products named: DUPIXENT, COSENTYX, TREMFYA, EBGLYSS, SKYRIZI, NEMLUVIO, Sotyktu, OTEZLA.
Industry payments across AL — which companies pay providers there.
